norketamine has been researched along with Neuralgia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buvanendran, A; Das, V; Kroin, JS; Moric, M | 1 |
Chong, C; Ilett, KF; Jenkins, B; Page-Sharp, M; Schug, SA | 1 |
Aarts, L; Dahan, A; Morariu, A; Niesters, M; Swartjes, M | 1 |
Dahan, A; Niesters, M | 1 |
Breivik, H; Eide, PK; Stubhaug, A; Øye, I | 1 |
1 review(s) available for norketamine and Neuralgia
Article | Year |
---|---|
Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain.
Topics: Animals; Chronic Disease; Disease Models, Animal; Humans; Ketamine; Neuralgia; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate | 2012 |
1 trial(s) available for norketamine and Neuralgia
Article | Year |
---|---|
Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aged; Analgesics; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Chronic Disease; Cross-Over Studies; Drug Stability; Drug Storage; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Middle Aged; Neuralgia; Temperature | 2009 |
3 other study(ies) available for norketamine and Neuralgia
Article | Year |
---|---|
Efficacy of the ketamine metabolite (2R,6R)-hydroxynorketamine in mice models of pain.
Topics: Animals; Disease Models, Animal; Female; Ketamine; Mice; Mice, Inbred C57BL; Neuralgia; Treatment Outcome | 2019 |
Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
Topics: Acute Disease; Analgesics; Animals; Chronic Disease; Cold Temperature; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Foot Injuries; Hyperalgesia; Infrared Rays; Ketamine; Motor Activity; Neuralgia; Pain; Pain Measurement; Physical Stimulation; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 2011 |
Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia.
Topics: Aged; Female; Herpesviridae Infections; Humans; Infusion Pumps, Implantable; Ketamine; Male; Neuralgia; Prospective Studies; Receptors, N-Methyl-D-Aspartate | 1995 |